#issues

The U.S. Food and Drug Administration (U.S. FDA) has issued an establishment inspection report (EIR) with a voluntary action indicated (VAI) classification to the Granules Pharmaceuticals Inc. (GPI)...

Receive the developer newsletter Product updates, how-tos, community spotlights and more. Delivered monthly to your inbox. Over the past month, we've reviewed reports that Claude's responses have...

In the interest of transparency, we would like to share the high-level details of the road map so that others can understand our priorities and plan on the basis of what we are doing. Our plans will...